Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Sanderson

Showing results (211-220 of 387) with videos related to

Pageof 39
Sort By:
The Journal of Biological Chemistry|December 23, 1994
Differential effects of monoclonal antibodies on activating transcription factor-1 and cAMP response element binding protein interactions with DNAD J Orten, J M Strawhecker, S D Sanderson, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1997
Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibioticsG P Gui, P R Thomas, M L Tizard, et al.
Nature Reviews. Gastroenterology & Hepatology|November 4, 2016
Patient optimization for surgery relating to Crohn's diseaseKamal V Patel, Amir A Darakhshan, Nyree Griffin, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 21, 2006
Expression of CD138 (Syndecan-1) in renal cell carcinoma is reduced with increasing nuclear gradeNeriman Gökden, Graham F Greene, Ilene B Bayer-Garner, et al.
Oncogenesis|March 2, 2016
Heparanase-induced shedding of syndecan-1/CD138 in myeloma and endothelial cells activates VEGFR2 and an invasive phenotype: prevention by novel synstatinsO Jung, V Trapp-Stamborski, A Purushothaman, et al.
Blood|September 28, 2002
Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cellsTherese Standal, Carina Seidel, Øyvind Hjertner, et al.
Therapeutic Advances in Chronic Disease|May 9, 2015
Optimizing the use of thiopurines in inflammatory bowel diseaseRishi M Goel, Paul Blaker, Alex Mentzer, et al.
Blood|May 16, 1998
Syndecan-1 is a multifunctional regulator of myeloma pathobiology: control of tumor cell survival, growth, and bone cell differentiationM V Dhodapkar, E Abe, A Theus, et al.
Journal of Medicinal Chemistry|September 16, 1994
Decapeptide agonists of human C5a: the relationship between conformation and spasmogenic and platelet aggregatory activitiesS D Sanderson, L Kirnarsky, S A Sherman, et al.
Microbial Genomics|May 7, 2024
Evaluation of the accuracy of bacterial genome reconstruction with Oxford Nanopore R10.4.1 long-read-only sequencingNicholas D Sanderson, Katie M V Hopkins, Matthew Colpus, et al.
Pageof 39

Showing results (211-220 of 387) with videos related to

Sort By:
Pageof 39
The Journal of Biological Chemistry|December 23, 1994
Differential effects of monoclonal antibodies on activating transcription factor-1 and cAMP response element binding protein interactions with DNAD J Orten, J M Strawhecker, S D Sanderson, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1997
Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibioticsG P Gui, P R Thomas, M L Tizard, et al.
Nature Reviews. Gastroenterology & Hepatology|November 4, 2016
Patient optimization for surgery relating to Crohn's diseaseKamal V Patel, Amir A Darakhshan, Nyree Griffin, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|June 21, 2006
Expression of CD138 (Syndecan-1) in renal cell carcinoma is reduced with increasing nuclear gradeNeriman Gökden, Graham F Greene, Ilene B Bayer-Garner, et al.
Oncogenesis|March 2, 2016
Heparanase-induced shedding of syndecan-1/CD138 in myeloma and endothelial cells activates VEGFR2 and an invasive phenotype: prevention by novel synstatinsO Jung, V Trapp-Stamborski, A Purushothaman, et al.
Blood|September 28, 2002
Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cellsTherese Standal, Carina Seidel, Øyvind Hjertner, et al.
Therapeutic Advances in Chronic Disease|May 9, 2015
Optimizing the use of thiopurines in inflammatory bowel diseaseRishi M Goel, Paul Blaker, Alex Mentzer, et al.
Blood|May 16, 1998
Syndecan-1 is a multifunctional regulator of myeloma pathobiology: control of tumor cell survival, growth, and bone cell differentiationM V Dhodapkar, E Abe, A Theus, et al.
Journal of Medicinal Chemistry|September 16, 1994
Decapeptide agonists of human C5a: the relationship between conformation and spasmogenic and platelet aggregatory activitiesS D Sanderson, L Kirnarsky, S A Sherman, et al.
Microbial Genomics|May 7, 2024
Evaluation of the accuracy of bacterial genome reconstruction with Oxford Nanopore R10.4.1 long-read-only sequencingNicholas D Sanderson, Katie M V Hopkins, Matthew Colpus, et al.
Pageof 39